Mario Sznol
Co-Director, Yale SPORE in Skin Cancer · Yale-New Haven Hospital
Credentials: · · · · ·
History
- Present
Yale SPORE in Skin Cancer · Yale-New Haven Hospital
- Present
- 1978–1982
- 1976–1979
- 1974–1978
University
Research
Safety, activity, and immune correlates of anti-PD-1 antibody in cancer
New England Journal of Medicine · 2012 · Last of 30 authors · 10,404 citations
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
New England Journal of Medicine · 2015 · 6,426 citations
Nivolumab plus ipilimumab in advanced melanoma
New England Journal of Medicine · 2013 · Last of 24 authors · 3,387 citations
67 papers
30 papers
- WU
21 papers
19 papers
18 papers
- DL
17 papers
- SA
17 papers
16 papers
Grants
- 2006–2018
- 2007–2013
Clinical trials
- 2006
A Study of Everolimus in Combination With Imatinib in Metastatic Melanoma
Principal investigator · Terminated · Phase 2
Yale University
- 2006–2008
Principal investigator · Terminated · Phase 1
Yale University
- 2005
Principal investigator · Completed · Phase 1
National Cancer Institute (NCI)
- 2003–2008
VNP40101M and Cytarabine in Treating Patients With Hematologic Malignancies
Study chair · Completed · Phase 1
Vion Pharmaceuticals